Navigation Links
Peripheral Vascular Device Market in the APAC Region 2010-2014
Date:10/12/2011

NEW YORK, Oct. 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Peripheral Vascular Device Market in the APAC Region 2010-2014

http://www.reportlinker.com/p0655254/Peripheral-Vascular-Device-Market-in-the-APAC-Region-2010-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

TechNavio's analysts forecast the Peripheral Vascular Devices market in the APAC region to grow at a CAGR of 11 percent for the period 2010–2014. One of the key factors contributing to this market growth is the increase in abdominal aortic aneurysms and peripheral arterial disease. The Peripheral Vascular Devices market in the APAC region has also been witnessing an increase in the growth of vascular stents in Japan. However, infections from peripheral vascular implantation and surgeries could pose a challenge to the growth of this market.

Key vendors dominating this market include Medtronic Inc., Abbott Laboratories, Boston Scientific Corp., Cordis Corp., and Cardiac Science Corp.

TechNavio's Peripheral Vascular Device Market in the APAC Region 2010–2014 report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the APAC region and covers the products used for PVD treatments and surgeries. This report also includes a discussion on key vendors operating in this market.

Key questions answered in this report:

What will the market size be in 2014 and at what rate will it grow?

What key trends is this
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
2. Global Peripheral Vascular Devices Market 2010-2014
3. BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study
4. Resource Now Available to Help Clinicians Reduce Risk of Blood Exposure from Short Peripheral IV Catheter Insertion
5. Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant
6. Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions
7. New Study Shows Tapentadol Extended Release (ER) May Significantly Reduce Average Pain Intensity for Diabetic Patients Suffering From Painful Peripheral Neuropathy
8. Reportlinker Adds Overview of the Western European Peripheral Interventional Devices Market
9. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
10. First Hotspur Peripheral Angioplasty Case Completed
11. Vermillion Announces Issuance of Patent for Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Increasing requirements, including rising surface ... gaskets indispensable in the chemical and pharmaceutical industries. ... pose major challenges to their performance. Freudenberg-NOK Sealing ... different materials whose scope covers the given requirements ... white FG-360, based on DIN 28091-3, is completely ...
(Date:5/21/2015)... , May 21, 2015  BioClinica®, Inc., ... provider, today announced it has partnered with Kinapse ... clinical trials using BioClinica,s Compass Intelligent Monitoring solution. ... can make a real difference in clinical research," ... excited about this collaboration as it helps move ...
(Date:5/21/2015)...  AbbVie (NYSE: ABBV ) announced today the ... announced offer to acquire each outstanding share of common ... cash and AbbVie common stock, as described in the ... and Exchange Commission by AbbVie on March 23, 2015, ... offer will expire at 5:00 p.m., New ...
Breaking Medicine Technology:Flat gaskets for especially demanding applications in the processing industry 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4
... The U.S. Food and Drug Administration today approved ... thyroid cancer who are ineligible for surgery and who ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... gland, which is located in the neck. Medullary thyroid ...
... Pure Biomed LLC has launched a full line ... for quick, temporary relief of nerve pain caused by ... damage.  Reunion is the only full line of skin ... Reunion products were developed from the ground up in ...
Cached Medicine Technology:FDA Approves New Treatment for Rare Form of Thyroid Cancer 2FDA Approves New Treatment for Rare Form of Thyroid Cancer 3Affordable Nerve Pain Treatment Now Available in the U.S. 2
(Date:5/21/2015)... Md. (PRWEB) May 21, 2015 The ... the University of Maryland, Baltimore Commercial Advisory Board has ... Maryland Health Care System as one of two $50,000 ... their ankle robot research, known as Anklebot. Developed ... Excellence, in collaboration with the University of Maryland School ...
(Date:5/21/2015)... 21, 2015 Bird B Gone, the leader ... recently added new sizes of the Bird Spike 2001 to ... stainless steel bird spike is specifically designed to reduce ... on roof lines, parapet walls, I-beams, window ledges and more. ... 100 foot boxes, allowing customers to buy the right amount ...
(Date:5/21/2015)... ARBOR, Mich. (PRWEB) May 21, 2015 ... the opposite effect on those with celiac disease according ... More than half of the probiotics tested in the ... in foods and dietary supplements and cause gastrointestinal inflammation ... , Companies aiming to gain consumer trust in gluten-free ...
(Date:5/21/2015)... An existing anti-stroke drug is an effective treatment ... mucus overproduction, improve bacterial clearance and reduce hearing ... and the University of Rochester. , The findings, ... could result in a novel, non-antibiotic treatment for ... drug delivery. Vinpocetine, the drug involved in the ...
(Date:5/21/2015)... 2015 Louis Kraml, CEO of Bingham ... new project and website—CancerTreatmentInfo.org. , With over 40 years ... about how vicious and insidious cancer can be, Mr. ... being treated and cared for. As such, he founded ... safe place where cancer patients, survivors, and family members ...
Breaking Medicine News(10 mins):Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 2Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 3Health News:New Cancer Treatment Website Revolutionizes How Cancer Treatment Information is Being Disseminated 2Health News:New Cancer Treatment Website Revolutionizes How Cancer Treatment Information is Being Disseminated 3
... , MORRISTOWN, N.J., July 28 Watson Pharmaceuticals, ... and specialty branded pharmaceuticals, today announced a license agreement with ... generic version of Ferrlecit (sodium ferric gluconate complex in sucrose ... anemia in hemodialysis patients receiving supplemental epoetin therapy. , ...
... pose no great risk to most people; consumer organization aghast ... health authorities on Tuesday placed tighter safety controls on ... and Drug Administration will now categorize the fillings as Class ... risk. Class II devices usually carry some kind of precautions ...
... , , 100% Oxygen Environment ... , SEATTLE, July 28 Northwest Hospital & Medical ... chambers and the launch of hyperbaric oxygen therapy services offered through ... , Hyperbaric oxygen chambers create a 100% oxygen environment, ...
... bypass could be a cause, expert says, , TUESDAY, July ... could be a severe shortage of cardiothoracic surgeons at a ... for surgical procedures that fall under their purview, a new ... of care and delays in care for people needing heart ...
... , , AVON, Conn., July ... its Avon facility,s certification to the international management system standard ... OFS Specialty Photonics Division facilities have maintained ISO 9001 certification ... manufacturing. The Avon facility has taken the additional step ...
... , , WASHINGTON, July 28 ... Action, the legislative lobbying arm of Family Research Council, ... to President Obama,s proposed government takeover of the health care system. ... leaders to discuss the moral, ethical, and financial dangers of President ...
Cached Medicine News:Health News:Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R) 2Health News:FDA Calls for Stricter Controls on Mercury Fillings 2Health News:FDA Calls for Stricter Controls on Mercury Fillings 3Health News:FDA Calls for Stricter Controls on Mercury Fillings 4Health News:Northwest Hospital Introduces Hyperbaric Oxygen Therapy 2Health News:Heart Surgeon Shortage Predicted 2Health News:Heart Surgeon Shortage Predicted 3Health News:Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification 2Health News:Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification 3
McPherson curved tying forceps is long has curved shafts with tying platform 4 mm, serrated handle and polished finish. Overall length 110 mm....
Kelman - McPherson tying forceps with serrated handle, platform 4 mm and overall length of 85 mm....
Castroviejo tying forceps, straight....
Moria tying forceps are straight, very delicate platforms for 10-0 and 11-0 monofilament. Platforms fully meet to hold suture firmly....
Medicine Products: